BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 3, 2011
View Archived Issues
Abciximab combined with heparin may be useful to treat stroke
Read More
Omeros identifies compounds that interact with GPCRs linked to metabolic and psychotic disorders
Read More
Solvay's SLV-338 alleviates symptoms of pulmonary hypertension in vivo
Read More
Novel MEK 1 inhibitors synthesized at Novartis
Read More
Athersys reports interim data from ongoing phase I MultiStem study
Read More
Preliminary phase III data presented at ASCO on bosutinib versus imatinib in Ph+ CML
Read More
Proactivator polypeptide described as new biomarker in prostate cancer
Read More
New data disclosed on duloxetine in chronic depression, MDD and GAD
Read More
Gilead presents new voltage-gated Na(V)1.5 sodium channel blockers
Read More
Novadex Pharmaceuticals discloses novel renin inhibitors
Read More
Grindeks claims new cognition-enhancing piracetam derivative enantiomer
Read More
New ghrelin receptor antagonists and/or inverse agonists synthesized
Read More
Novel 9-aminoacridine derivatives for cancer presented
Read More
Immunovaccine's phase I DPX-0907 trial meets primary objective
Read More
Asimadoline receives FDA fast track status for diarrhea-predominant irritable bowel syndrome
Read More
Ono and Daninippon Sumitomo to codevelop limaprost for carpal tunnel syndrome
Read More
Recruitment begins in phase Ib Ampion trial in osteoarthritis of the knee
Read More
Phase III data reported on CVT-E002 for acute respiratory illness in chronic lymphocytic leukemia
Read More
Aastrom's RESTORE-CLI trial meets primary safety and efficacy endpoints
Read More
Week 56 data consistent with earlier results in phase III lomitapide trial in HoFH
Read More
Kyowa Hakko Kirin and Valeant terminate North American licensing agreement for KW-6002
Read More
Bristol-Myers Squibb and Roche enter agreement to evaluate ipilimumab/vemurafenib combination
Read More
AVEO and Centocor Ortho Biotech enter license agreement for antibodies targeting MSP receptor
Read More
Lpath reports encouraging preclinical data on Lpathomab
Read More
GSK and Theravance provide results from two pivotal phase III Relovair trials in COPD
Read More
FDA finds no evidence of increased risk of cancer in safety review of ARBs
Read More
